Literature DB >> 26209139

Selective loss of dopaminergic neurons in the substantia nigra pars compacta after systemic administration of MPTP facilitates extinction learning.

Ken-ichi Kinoshita1, Yayoi Tada2, Yoshikage Muroi3, Toshihiro Unno4, Toshiaki Ishii5.   

Abstract

AIMS: Parkinson's disease (PD) is a neurodegenerative disorder characterized by progressive loss of dopaminergic (DAergic) neurons in the substantia nigra pars compacta (SNpc). In PD, thinking and retrieval deficits often arise from cognitive impairments. However, the mechanism of cognitive disorders in PD remains unknown. Therefore, we investigated cognitive function in PD model mice produced by intraperitoneal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), which specifically destroys the DAergic neurons in the SNpc. MAIN
METHODS: We evaluated the cognitive function of MPTP-treated mice (PD mice) using the contextual fear conditioning test. In the test, each experiment consists of three phases: training, re-exposure, and testing. Mice were trained with a foot shock (a weak unconditioned stimulus: 1mA/2s duration, once, or an intense unconditioned stimulus: 2mA/2s duration, twice), and 24h later, mice were re-exposed to the training context for 3min to determine reconsolidation or 30min to determine extinction. The percentage of time spent freezing was measured during the test session as indexes of memory consolidation, reconsolidation, and extinction. KEY
FINDINGS: Reconsolidation of PD mice occurred normally but memory extinction was facilitated in PD mice compared to control mice. Moreover, memory retention in PD mice was attenuated earlier than in controls following repeated conditioned stimuli every day. SIGNIFICANCE: PD mice with selective loss of DAergic neurons in the SNpc showed attenuated memory retention, probably via facilitated extinction learning.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dopamine; Extinction; MPTP; Parkinson's disease; Reconsolidation

Mesh:

Substances:

Year:  2015        PMID: 26209139     DOI: 10.1016/j.lfs.2015.07.017

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

1.  FTY720 Inhibits MPP+-Induced Microglial Activation by Affecting NLRP3 Inflammasome Activation.

Authors:  Shu Yao; Longjun Li; Xin Sun; Jun Hua; Keqi Zhang; Li Hao; Lixin Liu; Dongyan Shi; Hong Zhou
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-08       Impact factor: 4.147

Review 2.  Brain Cell Type-Specific Nuclear Proteomics Is Imperative to Resolve Neurodegenerative Disease Mechanisms.

Authors:  Ruth S Nelson; Eric B Dammer; Juliet V Santiago; Nicholas T Seyfried; Srikant Rangaraju
Journal:  Front Neurosci       Date:  2022-06-16       Impact factor: 5.152

Review 3.  Pharmacological modulation of phosphodiesterase-7 as a novel strategy for neurodegenerative disorders.

Authors:  Heena Khan; Chanchal Tiwari; Amarjot Kaur Grewal; Thakur Gurjeet Singh; Simran Chauhan; Gaber El-Saber Batiha
Journal:  Inflammopharmacology       Date:  2022-10-22       Impact factor: 5.093

4.  Altered basal forebrain BOLD signal variability at rest in posttraumatic stress disorder: A potential candidate vulnerability mechanism for neurodegeneration in PTSD.

Authors:  Isadora Olivé; Nikos Makris; Maria Densmore; Margaret C McKinnon; Ruth A Lanius
Journal:  Hum Brain Mapp       Date:  2021-05-07       Impact factor: 5.399

5.  The Effects of Age, from Young to Middle Adulthood, and Gender on Resting State Functional Connectivity of the Dopaminergic Midbrain.

Authors:  Andrew C Peterson; Sheng Zhang; Sien Hu; Herta H Chao; Chiang-Shan R Li
Journal:  Front Hum Neurosci       Date:  2017-02-07       Impact factor: 3.169

6.  Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson's disease and schizophrenia.

Authors:  Ashish Kumar Gupta; Ruchika Pokhriyal; Uddipan Das; Mohd Imran Khan; Domada Ratna Kumar; Rishab Gupta; Rakesh Kumar Chadda; Rashmi Ramachandran; Vinay Goyal; Manjari Tripathi; Gururao Hariprasad
Journal:  Neuropsychiatr Dis Treat       Date:  2019-07-19       Impact factor: 2.570

7.  Effects of Sub-Chronic MPTP Exposure on Behavioral and Cognitive Performance and the Microbiome of Wild-Type and mGlu8 Knockout Female and Male Mice.

Authors:  Eileen Ruth S Torres; Tunde Akinyeke; Keaton Stagaman; Robert M Duvoisin; Charles K Meshul; Thomas J Sharpton; Jacob Raber
Journal:  Front Behav Neurosci       Date:  2018-07-18       Impact factor: 3.558

8.  Editorial for the Special Issue "Animal Models of Parkinson's Disease and Related Disorders".

Authors:  Yuzuru Imai
Journal:  Int J Mol Sci       Date:  2020-06-15       Impact factor: 5.923

9.  Serotonin 5-HT4 Receptor Agonists Improve Facilitation of Contextual Fear Extinction in an MPTP-Induced Mouse Model of Parkinson's Disease.

Authors:  Toshiaki Ishii; Ken-Ichi Kinoshita; Yoshikage Muroi
Journal:  Int J Mol Sci       Date:  2019-10-26       Impact factor: 5.923

Review 10.  Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis.

Authors:  Pablo Bascuñana; Luisa Möhle; Mirjam Brackhan; Jens Pahnke
Journal:  Drugs R D       Date:  2020-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.